Related Experiment Video
Updated: Aug 3, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Coronary restenosis: a review of mechanisms and management
Vivek Rajagopal1, Stanley G Rockson
1Division of Cardiovascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, California 94305, USA.
Abstract:
Percutaneous coronary interventions represent an attractive alternative to surgical revascularization; nevertheless, these techniques continue to be characterized by their propensity to elicit restenosis. Despite an exhaustive search for an effective pharmacotherapy to treat or prevent restenosis, hundreds of clinical trials have failed to identify an agent with proven therapeutic benefit. Recently, however, the Food and Drug Administration approved intracoronary radiation (brachytherapy) as a viable therapeutic option for in-stent stenosis. In addition, recent randomized trials have shown encouraging results for drug-eluting stents. This article reviews the pathophysiology of restenosis, along with current and future treatment options.
Insights
Percutaneous coronary interventions are effective but can cause restenosis. Intracoronary radiation and drug-eluting stents show promise for preventing restenosis after these procedures.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Biology
Background:
- Percutaneous coronary interventions (PCI) are alternatives to surgical revascularization but are limited by restenosis.
- Pharmacological treatments for restenosis have largely failed despite extensive research.
- In-stent restenosis remains a significant clinical challenge following PCI.
Purpose of the Study:
- To review the pathophysiology of restenosis.
- To discuss current treatment options for restenosis.
- To explore future therapeutic strategies for preventing restenosis.
Main Methods:
- Literature review of pathophysiology and treatment of restenosis.
- Analysis of recent clinical trial data on intracoronary radiation and drug-eluting stents.
- Synthesis of information on current and emerging therapies.
Main Results:
- Intracoronary radiation (brachytherapy) is FDA-approved for in-stent stenosis.
- Drug-eluting stents have demonstrated encouraging results in recent randomized trials.
- No single pharmacotherapy has proven effective for preventing restenosis.
Conclusions:
- Restenosis following PCI requires ongoing research and development of effective treatments.
- Intracoronary radiation and drug-eluting stents represent significant advancements.
- A comprehensive understanding of restenosis pathophysiology is crucial for future therapeutic innovation.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care

